Mehmet Ali ERDOGAN, Yahya ATAYAN, Mehmet Veysi DEVİREN, Ayetullah APAK, Sendag YASLIKAYA, Ali Rıza ÇALIŞKAN

The correlation between cytological examination of ascitic fluid and serum ascites albumin gradient in the differential diagnosis of ascites

Aim: The accumulation of fluid in pathological quantities in the peritoneal cavity is called ascites. In every newly diagnosed ascites, necessary investigations should be conducted by puncturing ascitic fluid. In this study, we aimed to investigate whether there is any correlation between cytological examination of ascitic fluid and serum ascites albumin gradient (SAAG) in the determination of etiologic causes of ascites.Material and Method: The files of the patients who were admitted to our clinic for the investigation of their ascites etiology between May 2014 and May 2018, were analyzed retrospectively. Pathology reports of the patients whose SAAG was calculated by taking the difference between serum albumin values and simultaneously taken ascitic fluid albumin and whose ascitic fluid cytology examination was performed, were recorded. The data of 248 patients with clinical diagnosis were included in the study. Patients with SAAG

PDF

___

1. Zeybel M, Çolakoğlu Ö, Uğur F. Assit, In: Ünsal B. Editör. Portal hipertansiyon ve komplikasyonları, 1.baskı. İzmir. Meta Basım 2003;123-59.
2. Runyon BA. Management of adult patients with ascites due to cirrhosis: an update. Hepatology 2009;49:2087-107.
3. Hoefs JC. Serum protein concentration and portal pressure determine the ascitic fluid protein concentration in patients with chronic liver disease. J Lab Clin Med 1983;102:260-73
4. Runyon BA, Montana AA, Akriviadis EA, et al. The serum-ascites albumin gradient is superior to exudate-transudate concept in differential diagnosis of ascites. Ann Intern Med 1992;117:215-20.
5. Gerbes AL, Jüngst D, Xie Y et al. Ascitic fluid analysis for the differentiation of malignancy-related and nonmalignant ascites. Proposal of a diagnostic sequence. Cancer 1991;68:1808-14.
6. Runyon BA, Hoefs JC, Morgan TR. Ascitic fluid analysis in malignancy-related ascites. Hepatology 1988;8:1104-9.
7. Castaldo G, Oriani G, Cimino L, et al. Total discrimination of peritoneal malignant ascites from Cirrhosis-and hepatocarcinoma-associated ascites by assays of ascitic cholesterol and lactate dehydrogenase. Clin Chem 1994;40:478-83.
8. Parsons SL, Watson SA, Steele RJ. Malignant ascites. Br J Surg 1996;83:6-14.
9. Pare P, Talbot J, Hoefs JC. Serum ascites albumin concentration gradient: a physiological approach to the differantial diagnosis of ascites. Gastroenterology 1983;85:240-4.
10. Reynolds TB. Ascites. Clin Liver Dis 2000;4:151-68.
11. Moore KP, Wong F, Gines P, et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology 2003;38:258-66.
12. Ökten A, Mungan Z, Çakaloğlu Y, et al. Assit: Tanı-Ayırıcı tanı, klinik özellikler: Gastroenterohepatoloji. Nobel Tıp Kitapevleri, 2001:345-68.
13. Al-Knawy BA, Etiology of ascites and the diagnostic value of serum-ascites albumin gradient in non-alcohol liver disease. Ann Saudi Med 1997;17:26-8.
14. Karaaslan Y, Gürel S, Dolar ME, et al. Diagnostic value of tumor markers in malignant ascites. Turkiye Klinikleri Journal of Gastroenterohepatology 1999;10:12732.
15. Garrison RN, Kaelin LD, Galloway RH, et al. Malignant ascites. Clinical and experimental observations. Ann Surg 1986;203:644-51.